HYAL6P: A Potential Drug Target for Hyaluronic Acid Degradation

Target Name: HYAL6P

NCBI ID: G26062

HYAL6P

Other Name(s): Hyaluronidase 6, pseudogene | hyaluronidase 6, pseudogene | HYAL6 | HYALP1

HYAL6P: A Potential Drug Target for Hyaluronic Acid Degradation

HYAL6P, also known as Hyaluronidase 6, is a protein that is expressed in various tissues throughout the body. It is a member of the hyaluronidase family, which is a group of enzymes that are involved in the degradation of hyaluronic acid, a component of connective tissue that is found in many different tissues throughout the body.

HYAL6P is primarily expressed in the liver, kidneys, and pancreas, and it is also found in various other tissues, including the heart, lungs, and gastrointestinal tract. It is a 21-kDa protein that has a molecular weight of 19,902 Da and a calculated pI of 6.4.

One of the unique features of HYAL6P is its catalytic activity. It is highly specific for the cleavage of hyaluronic acid by other enzymes, including hyaluronidase A (HYAL1) and hyaluronidase B (HYAL2). This means that when HYAL6P is present in a solution, it will only react with certain types of hyaluronic acid, and not with other types that are not present.

This specificity is important for HYAL6P's potential as a drug target. By selectively targeting hyaluronic acid degradation by HYAL6P, researchers may be able to develop drugs that are targeted specifically to this protein and have a reduced risk of unintended side effects.

In addition to its catalytic activity, HYAL6P has also been shown to play a role in the regulation of various cellular processes. For example, it has been shown to be involved in the degradation of extracellular matrix (ECM) components, which are important for tissue repair and regeneration. It has also been shown to be involved in the regulation of cell adhesion and migration, as well as in the regulation of inflammation.

Despite its potential as a drug target, little is currently known about the biology and metabolism of HYAL6P. There are currently no known treatments that target specifically to this protein, and more research is needed to understand its role in various biological processes and its potential as a drug target.

In conclusion, HYAL6P is a protein that is expressed in various tissues throughout the body and has been shown to play a role in the degradation of hyaluronic acid. Its catalytic activity and its potential involvement in various cellular processes make it an interesting candidate as a drug target. Further research is needed to understand its role in various biological processes and its potential as a drug target.

Protein Name: Hyaluronidase 6, Pseudogene

The "HYAL6P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HYAL6P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets